Get emailed when VTVT changes direction
Mkt Cap $122M
52wk $14.00 - $44.00
1h ago
Est. revisions:
+460.0%
(4 up, 0 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +3.1)
Factor Model
net +3.1 4.9 / 10
Est. Revisions
+1.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0
VTVT short interest jumps 37% to 112.7K shares
Watch: Watch updates from VTVT's Phase 3 Cadisegliatin trial and any milestones on the HPP737 partnership that could shift sentiment.
VTVT's short interest rose 37.1% to 112,740 shares, now 4.6% of its float and requiring 2.3 days to cover. This increase comes amid a 14% stock decline last week and a 19% drop from its 52-week high. Analyst targets average $53.33, while the company shows mixed insider activity and a strong current ratio of 13.5.
The rising short interest signals growing bearish sentiment, pressuring VTVT's stock amid ongoing financial challenges and revenue decline.
Evidence
3h ago
Short interest surged 37% to 112,740 shares
40d ago
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements
yahoo-finance
Fundamentals & Data ▾
vTv Therapeutics Inc.
Healthcare · Biotechnology
Mkt Cap
$122M
Beta
0.40
52w Range
$14.00 - $44.00
Short Interest
112,740 4.63%
Days to Cover
2.3 +71%
Technicals
downtrend
from 52w Hi
-19.0%
1w return
-14.1%
Insiders
mixed
0B / 0S
EPS Estimate
$0.21
+460.0% 30d
4up / 0dn
Est. Dispersion
924%
6 analysts
Analyst Target
$53
$44 - $67
Recent Filings & Data
insider trade
2
net selling
2 insiders · 2 transactions (30d)
Recent transactions
AKKARAJU SRINIVAS · award · $2,349,713
BAKER BROS ADVISORS, L.P. · award
3 signals · latest 3h ago
Get alerted when VTVT changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.